Sort by
Refine Your Search
-
Listed
-
Employer
- Nature Careers
- University of Michigan
- Genentech
- Indiana University
- Medical College of Wisconsin
- Rutgers University
- City of Hope
- Center for Biologics Evaluation and Research (CBER)
- University of Cincinnati
- University of Kansas Medical Center
- University of Michigan - Ann Arbor
- Amgen
- Cold Spring Harbor Laboratory
- Novartis
- Pfizer
- University of New Hampshire
- University of Texas Rio Grande Valley
- Washington University in St. Louis - Center for Genome Integrity
- 8 more »
- « less
-
Field
-
of Health (NIH) to support cutting-edge proteomics method development, this position offers an exciting opportunity to contribute to groundbreaking research projects aimed at understanding the proteomic
-
The Position We advance science so that we all have more time with the people we love. The Microchemistry, Proteomics, Lipidomics & Next Generation Sequencing department (MPL-NGS) develops and
-
team as a Post-Doctoral Fellow. This position offers a unique opportunity to contribute to the forefront of scientific discovery by developing innovative methods in single-cell proteomics and applying
-
-Doctoral Fellow. This position offers a unique opportunity to contribute to the forefront of scientific discovery by developing innovative methods in single-cell proteomics and applying them
-
The Position A position is available for a postdoctoral fellow with expertise in neuroscience, iPSC-derived models, and omics data to join the Departments of Microchemistry, Proteomics & Lipidomics
-
The Position We are seeking a highly motivated Postdoctoral Fellow to join the Microchemistry, Proteomics & Lipidomics (MPL) department. The successful candidate will develop a native mass
-
, proteome, and clinical data, to gain insights into the human immune system and protective immunity. A key part of the role will be to investigate how pre-existing immunity correlates with infection
-
transcriptomics/proteomics approaches, bioinformatics/modeling tools and clinical sample analyses, our dynamic group focuses on identifying novel targets overcoming resistance to state-of-art clinically approved
-
, molecular and cellular biology, transcriptomics and proteomics, induced pluripotent stem cell culture/differentiation, and mouse models of disease. Opportunities to become involved in clinical research
-
fundamental scientific questions. The experimental approaches we are currently using include: CRISPR genome editing, CUT&RUN/ChIP, scRNA-seq/scATAC-seq, 3D imaging/expansion microscopy, proteomics, hydrogel